Ranibizumab Intraocular and Tetracycline Mucous membrane, oral
Determining the interaction of Ranibizumab Intraocular and Tetracycline Mucous membrane, oral and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: tetracycline
Brand name: Ala-Tet, Brodspec, Panmycin, Sumycin, Tetracap, Tetracon, Robitet 500, Emtet-500
Synonyms: Tetracycline, Tetracycline (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab Intraocular-Tetracycline Topical application
- Ranibizumab Intraocular-Tetrahydrozoline (Nasal)
- Ranibizumab Intraocular-Tetrahydrozoline and zinc ophthalmic
- Ranibizumab Intraocular-Tetrahydrozoline Hydrochloride
- Ranibizumab Intraocular-Tetrahydrozoline ophthalmic
- Ranibizumab Intraocular-Tetrofosmin
- Tetracycline Mucous membrane, oral-Ranibizumab ophthalmic
- Tetracycline Mucous membrane, oral-Ranitidine
- Tetracycline Mucous membrane, oral-Ranitidine Capsule
- Tetracycline Mucous membrane, oral-Ranitidine Hydrochloride
- Tetracycline Mucous membrane, oral-Ranitidine Injection
- Tetracycline Mucous membrane, oral-Ranitidine Suspension